James M. Cornelius has been appointed chief executive officer of Bristol-Myers Squibb with a term through 2009. Mr. Cornelius has served as interim chief executive for the past eight months, since the departure of Peter Dolan. He has also been a member of the company’s board since January of 2005, previously serving as chairman and chief executive officer of Guidant Corp., chief financial officer of Eli Lilly and Co., and president and chief executive officer of IVAC Corp. “As w...